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SOCCs (store-operated Ca
2+ channels) are highly selective ion
channels that are activated upon release of Ca
2+ from intracellular
stores to regulate a multitude of diverse cellular functions. It
was reported previously that Golli-BG21, a member of the MBP
(myelin basic protein) family of proteins, regulates SOCE (store-
operated Ca
2+ entry) in T-cells and oligodendrocyte precursor
cells, but the underlying mechanism for this regulation is
unknown. In the present study we have discovered that Golli
can directly interact with the ER (endoplasmic reticulum) Ca
2+-
sensing protein STIM1 (stromal interaction molecule 1). Golli
interactswiththeC-terminaldomainofSTIM1inbothinvitroand
in vivo binding assays and this interaction may be modulated by
the intracellular Ca
2+ concentration. Golli also co-localizes with
full-length STIM1 and Orai1 complexes in HeLa cells following
Ca
2+ store depletion. Overexpression of Golli reduces SOCE in
HeLa cells, but this inhibition is overcome by overexpressing
STIM1. We therefore suggest that Golli binds to STIM1–Orai1
complexes to negatively regulate the activity of SOCCs.
Key words: calcium, endoplasmic reticulum (ER), Golli, myelin
basic protein (MBP), store-operated Ca
2+ entry (SOCE), stromal
interaction molecule 1 (STIM1).
INTRODUCTION
Ca
2+ signalling controls many cellular processes including cell
growth, secretion and proliferation [1,2]. Generation of Ca
2+
signals in non-excitable cells involves rapid IP3 (inositol 1,4,5-
trisphosphate)-dependent Ca
2+ release from intracellular stores
followed by external Ca
2+ entry through SOCCs (store-operated
Ca
2+ channels) [3–5]. These coupled processes are regulated
by two dynamic transmembrane proteins, the ER (endoplasmic
reticulum) Ca
2+ sensor protein STIM1 (stromal interaction
molecule1)[6–10]andthePM(plasmamembrane)proteinOrai1
[ 9 , 1 1 ] .S T I M 1i saC a
2+ sensor within the ER that oligomerizes
to form aggregates or ‘puncta’ in ER–PM junctions upon store
depletion [7,12]. Oligomerized STIM1 then binds to PM Orai1 to
activate Ca
2+ inﬂux [13,14]. Mutational analysis of the STIM1-
interacting domains revealed that the cytoplasmic C-terminus of
STIM1 is necessary and sufﬁcient for the activation of SOCC
inﬂux and its associated Ca
2+ release-activated Ca
2+ current
(ICRAC) [15]. More recently, a minimal region has been identiﬁed
within the C-terminus of STIM1, which is required to interact
with and activate Orai1 clustering and SOCC inﬂux [16–20].
A previous paper by Varnai et al. [21] suggested that STIM1
and Orai1 form part of a large macromolecular complex, which
may indicate the presence of other proteins within STIM1–
Orai1 clusters. One potential candidate for this is Golli protein,
encoded by the MBP (myelin basic protein) gene; Golli proteins
are alternative splice isoforms of the classic MBP proteins [22].
UnlikeMBP,whichisamajorconstituentofmyelininthenervous
system, Golli proteins are expressed ubiquitously, although their
functionisnotwellunderstood.TheBG21isoformofGolli(Golli-
BG21) is expressed at high levels in T-cells [23] where it acts as a
negative regulator of T-cell activation [22]. T-cells from Golli-
deﬁcient mice are hyperproliferative and exhibit increased IL
(interleukin)-2 production [24]. It has been shown that this is
due to enhanced SOCC inﬂux in Golli-deﬁcient cells, suggesting
that Golli is a negative regulator of SOCE (store-operated Ca
2+
entry) [24]. Conversely, overexpression of Golli-BG21 in Jurkat
T cells results in decreased SOCC inﬂux [24]. Golli-BG21 also
regulates voltage-gated Ca
2+ channels and SOCCs to mediate the
migration and proliferation of oligodendrocyte precursor cells
[25–27]. Interestingly, a fraction of Golli-BG21 is constitutively
localizedtolipidraftsatthePMandthisPMassociationincreases
following T-cell stimulation [24]. Mutation of the N-terminal
Golli myristoylation site, required for PM association, abolishes
its ability to regulate Ca
2+ inﬂux [24]. Golli-BG21 does not affect
the IP3-dependent release of Ca
2+ from internal stores, but rather
regulates store-depletion-induced Ca
2+ entry itself [24]. It is not
yet known how Golli-BG21 regulates SOCC activity in T-cells,
i.e. whether it is due to a direct effect on the channel itself or
through the regulation of the signalling pathway responsible for
SOCC activation. In the present study we show that Golli-BG21
interacts with the SOCC activator STIM1 and suggest that down-
regulation of SOCE is the likely consequence of this interaction.
MATERIALS AND METHODS
Plasmid construction
All expression vectors were purchased from Clontech, except
pGEX-6-P1, which was from GE Healthcare. The Golli-BG21–
GFP (green ﬂuorescent protein) plasmid was a gift from
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Dr Celia Campagnoni (University of California, Los Angeles,
School of Medicine, Los Angeles, CA, U.S.A.). For afﬁnity
chromatographyandbindingexperiments,theC-terminaldomain
of STIM1 (STIM1-CT; amino acids Met
241–L y s
685), the C-
and N-terminal domains of Orai1 [Orai-CT (amino acids
Ala
267–Ala
315) and Orai-NT (amino acids Met
1–Leu
86)] and
the full-length Golli-BG21 protein were subcloned into the
pGEX-6-P1 vector using BamHI/SacII for STIM1-CT, and
BamHI/XhoI for Golli and Orai1. For split YFP (yellow
ﬂuorescent protein) experiments, STIM1-CT and Golli-BG21
were subcloned into YFP-YN (N-terminal half of YFP) and
YFP-YC (C-terminal half of YFP) vectors respectively [28].
STIM1-CT was subcloned into pEYFP-N1 and YFP-YN using
HindIII/SacII and Golli-BG21 was subcloned into pmCherry-N1
(a gift from Dr Roger Y. Tsien, Department of Pharmacology,
University of California, San Diego, CA, U.S.A.) and YFP-YC
using XhoI/SacII for co-localization experiments. Construction
of STIM1–EYFP (enhanced YFP) and mCherry–Orai1 has been
described previously [29], as has construction of pmCherry–Rit1
[30].
Afﬁnity chromatography and MALDI–TOF (matrix-assisted
laser-desorption ionization–time-of-ﬂight) MS
Extracts of bovine brain were prepared as described previously
[31]. GST (glutathione transferase) fusion proteins were
expressed in Escherichia coli, immobilized on to glutathione–
cellulose beads (Bioline) and incubated with 1 ml of extracted
cytosolic bovine brain proteins on a rotator for 2 h at 4◦C. The
beads were washed with wash buffer [25 mM Tris/HCl, pH 7.8,
50 mM KCl and 1 mM DTT (dithiothreitol)] and proteins eluted
by boiling in Laemmli buffer. Eluted proteins were puriﬁed by
methanol precipitation, denatured by boiling in SDS buffer, and
analysed by SDS/PAGE. Protein bands of interest were excised
and subjected to in-gel tryptic digestion and MALDI–TOF MS as
described previously [32].
Binding assays
GST control or GST–Golli fusion proteins were immobilized on
to glutathione–cellulose beads and incubated with 2 μMS T I M 1 -
CT protein, which had been treated with the PreScission protease
(GE Healthcare) to cleave the GST tag. Samples were eluted
by boiling in Laemmli buffer and analysed by Western blotting
using an anti-STIM1 antibody (1:1000 dilution; ProSci) and a
HRP (horseradish peroxidase)-linked anti-(rabbit Ig) secondary
antibody.
Cell culture and transfection
HeLa cells were maintained as described previously [29]. Cells
were transfected with 1 μg of the plasmid(s) of interest using
GeneJuice (Merck Biosciences) and cultured for 24 h.
BiFC (bimolecular ﬂuorescence complementation) assays and
co-localization studies
For BiFC assays, HeLa cells were transfected with Golli-BG21–
YC and STIM1-CT–YN constructs either alone or together. For
further control experiments, HeLa cells were transfected with
the empty BiFC vectors (YFP-YC and YFP-YN), Golli-BG21–
YC and YFP-YN, or STIM1-CT–YN and YFP-YC. Cells were
treated with 2 μM thapsigargin at room temperature (23◦C) for
90 min before imaging. For co-localization studies, HeLa cells
were co-transfected with mCherry–Orai1 together with Golli-
BG21–YC/STIM1-CT–YN or STIM1-CT–YFP, STIM1–EYFP
and mCherry–Golli, or triply transfected with STIM1–EYFP,
mCherry–Orai1 and Golli-BG21–GFP and imaged 24 h post-
transfection.
Ca2+ measurements
Cells grown on glass-bottomed dishes were placed in standard
buffer (10 mM Hepes, pH 7.3, containing 140 mM NaCl 4.7 mM
KCl, 2 mM CaCl2,1 . 1 3 m MM g C l 2 and 10 mM glucose) and
loaded with 5 μM Fluo 4 AM (Fluo 4 acetoxymethyl ester)
for 30 min at room temperature before washing in Ca
2+-free
standard buffer. Ca
2+ imaging was carried out using a Leica
AOBS SP2 microscope. HeLa cells expressing STIM1–EYFP,
Golli–mCherry or a combination of both were pretreated with
2 μM thapsigargin (Calbiochem) in the absence of extracellular
Ca
2+ for 10 min to deplete stores; 2 mM Ca
2+ was then added to
activate SOCE [30].
Quantiﬁcation of STIM1 puncta
Quantiﬁcation of STIM1–EYFP puncta was performed as
described previously [30]. Brieﬂy, puncta were selected as spots
of high ﬂuorescence intensity ranging from approx. 0.5–1.0 μm
in diameter. Accuracy of puncta quantiﬁcation was veriﬁed by
independent blind counting.
Quantiﬁcation of Golli–mCherry ﬂuorescence
To determine the extent of Golli–mCherry ﬂuorescence in
cells overexpressing STIM1–EYFP compared with cells that do
notoverexpressSTIM1,regionsofinterestweredrawnaroundthe
outside of each cell. Fluorescence values were calculated on
the basis of the mean ﬂuorescence per pixel within the cell rather
than total ﬂuorescence to avoid problems arising from variations
in the size of the selected regions of interest.
RESULTS
To search for novel binding partners for STIM1 and
Orai1, we performed pull-down experiments on immobilized
cytosolic domains of the STIM1 and Orai1 GST-fusion pro-
teins [GST–STIM-CT (∼80 kDa), GST–Orai1-CT (∼34.5 kDa)
and GST–Orai1-NT (∼33 kDa)] using bovine brain cytosol
(Figure 1A). MALDI–TOF MS analysis of unique protein bands
fromthepull-downidentiﬁedMBP(eightmatchingpeptideswith
39% sequence coverage), as a protein of approx. 25 kDa in size,
which bound to the C-terminus of STIM1. Western blotting using
ananti-MBPantibodyconﬁrmedthatMBPboundspeciﬁcallyand
efﬁciently to STIM1 and also bound to the N-terminus of Orai1
(Figure 1B). Note that a similar sized polypeptide was present in
the control GST pull-down sample (Figure 1A). The identity of
this polypeptide was not established, but it was not recognized by
the anti-MBP antibody (Figure 1B). The ﬁnding of MBP binding
was surprising, since classic MBP itself is required for central
nervous system myelination and has not been implicated in the
activity of SOCCs. The Golli family of proteins are alternatively
spliced variants of classical MBPs, which have been shown
to mediate signal transduction in T-cells through the negative
regulation of SOCCs [24]. As Golli proteins contain MBP
epitopes, we hypothesized that Golli may interact with STIM1 to
exert its effect on SOCE. We assessed whether the C-terminus of
STIM1interactsdirectlywithGolliusinganinvitrobindingassay.
ArecombinantGST–Golli-BG21fusionprotein(∼57.5 kDa)was
expressed in E. coli and immobilized on to a glutathione afﬁnity
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Figure 1 Golli binds to the C-terminus of STIM1
(A) Coomassie-Blue-stained gel of eluates from GST, GST–Orai1-CT, GST–Orai1-NT
and GST–STIM1-CT pull-down assays. GST columns were run in parallel with GST–Orai1-CT,
GST–Orai1-NT and GST–STIM1-CT and incubated with bovine brain cytosol extract. Samples
were eluted by boiling in Laemmli buffer. Eluted proteins were separated by SDS/PAGE.
Subsequently, proteins were excised from gels and analysed by MALDI–TOF MS. MBP (arrow)
wasidentiﬁedasaGST–STIM1-CTbindingpartner.(B)Westernblottinganalysisofeluatesfrom
GST, GST–Orai1-CT, GST–Orai1-NT and GST–STIM1-CT pull-down assays. Membranes were
immunoblotted (IB) with anti-MBP antibody. (C) Puriﬁed STIM1-CT binding to GST–Golli.
GST–Golli and GST–STIM1-CT fusion proteins were puriﬁed using glutathione–cellulose
beads. GST–STIM1-CT was cleaved with PreScission protease to remove the GST tag.
Glutathione–cellulose beads containing equal amounts of GST or GST–Golli were incubated
with 2μM STIM1-CT. Proteins were eluted in wash buffer containing 1mM NaCl, methanol
precipitated and boiled in Laemmli buffer. Samples were separated by SDS/PAGE and analysed
by Western blotting with anti-STIM1 antibody. The molecular mass in kDa is indicated on the
left-hand side of the gels.
resin. Immobilized GST–Golli-BG21 or GST control protein
(∼26 kDa) was incubated with PreScission-cleaved STIM1-
CT (∼54 kDa). Western blotting analysis revealed that
STIM1-CT bound speciﬁcally to the GST–Golli-BG21 protein,
but not to the GST control (Figure 1C), conﬁrming that the C-
terminus of STIM1 does indeed interact with Golli in vitro.N o t e
that in these experiments the glutathione beads were incubated
with levels of GST or GST–Golli-BG21 that resulted in a 1.4-
fold higher level of GST so that lack of binding of STIM1-CT
to GST-loaded beads was not a consequence of the relative GST
concentration.InsimilarexperimentsbindingofOrai-NTtoGST–
Golli-BG21 could not be detected (results not shown).
To investigate further the possible interaction of STIM1 and
Golli-BG21 in a cellular context, we expressed these two proteins
inHeLacellsusingaBiFCassay[33].ThisBiFCsysteminvolved
the fusion of the complementary fragments of EYFP (i.e. YN and
YC) to two proteins of interest. If these proteins interact the
EYFP fragments come close enoughto fold and form a functional
ﬂuorescent EYFP protein [28]. In these experiments, YC and
YN were fused to the C-termini of the STIM1-CT (STIM1-
CT–YN) and Golli (Golli-BG21–YC) proteins and expressed in
HeLa cells along with a mCherry-tagged Rit1 (Ras-like without
CAAX 1) tail protein (mCherry–Rit1), described previously
[30], as a marker to identify transfected cells. No detectable
ﬂuorescence was observed in untreated cells (Figure 2A).
Transfected cells were treated with thapsigargin for 60–90 min
at room temperature in 2 mM external Ca
2+ before imaging with
a confocal microscope. EYFP ﬂuorescence was detected at the
PM in treated cells expressing STIM1-CT–YN and Golli-BG21–
YC at approx. 90 min following the addition of thapsigargin
(Figure 2B), which is consistent with the time course described
for the refolding of EYFP at room temperature [33]. EYFP
ﬂuorescence was distributed throughout the PM, but no puncta
were visible. The uniform PM EYFP ﬂuorescence observed was
consistent with the previous ﬁnding that although STIM1-CT
expression gives constitutive activation of the ICRAC, it does not
form puncta at the PM [34] as it requires an ER localization to
oligomerize prior to translocation to ER–PM junctions [34,35].
We also observed that STIM1-CT–EYFP co-localizes with the
mCherry–Orai1 protein at the PM in HeLa cells, but does not
form visible puncta (results not shown). No detectable EYFP
ﬂuorescencewasobservedinthapsigargin-treatedcellsexpressing
either the STIM1–YN or Golli-BG21–YC fusion protein alone
(Figures2Cand2D)oralongwiththeappropriatecomplementary
fragment of YFP (Figures 2E and 2F). Similarly, co-expression
of both EYFP fragments failed to produce a ﬂuorescent signal
and served as a negative control (Figure 2G). There are two
possibilities to explain why EYFP ﬂuorescence was observed
at the PM only following thapsigargin treatment. First, STIM1-
CT–YN may associate with endogenous STIM1 puncta enabling
it to interact with Golli-BG21–YC at the PM. Secondly, it is also
possible that a change in cytosolic Ca
2+ concentration may be
required to modulate an interaction between STIM1-CT–YN and
Golli-BG21–YC. To investigate this, HeLa cells expressing both
constructs were treated with 100 μM histamine, which should
induce transient oscillations in cytoplasmic Ca
2+, in place of
thapsigargin. Plasmalemmal EYFP ﬂuorescence formation was
observed (Figure 2H) even though full-length STIM1–EYFP did
not reveal substantial sustained puncta formation under these
conditions (results not shown) suggesting that an increase in
cytosolic Ca
2+ from intracellular stores modulates the interaction
between STIM1-CT and Golli-BG21. PM EYFP ﬂuorescence
was also observed in cells that were not co-transfected with
mCherry–Rit1 (results not shown), eliminating the possibility
that the transfection marker was targeting the BiFC constructs
to the PM. The emission spectrum for the ﬂuorescence observed
with STIM1–YN/Golli-BG21–YC was close to that of EYFP
(Figure 2I), conﬁrming that the ﬂuorescence observed was due to
formation of functional EYFP. The BiFC assay was also used
to determine whether Golli interacts with full-length STIM1–YN
or Orai1–YN. However, EYFP ﬂuorescence was not observed
in cells transfected with Golli–YC and Orai1–YN or full-length
STIM1–YN that had been treated with thapsigargin for 90 min
(results not shown).
Interestingly, when mCherry-Orai1 was co-expressed with
STIM1-CT–YN/Golli-BG21–YC in HeLa cells, the EYFP
ﬂuorescence clearly overlapped with the mCherry–Orai1 signal
(Figure3A).Furthermore,aGolli-BG21–GFPfusionco-localized
with both mCherry–Orai1 and STIM1-CT–EYFP in HeLa cells
(Figure 3B and insert). This led us to examine whether Golli co-
localizes with full-length STIM1 and Orai1 in puncta, thereby
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Figure 2 STIM1-CT–YN and Golli-BG21–YC fusion proteins reconstitute EYFP ﬂuorescence at the PM
HeLa cells were co-transfected with mCherry–Rit1 as a transfection marker (right-hand panels). At 24 h post-transfection, cells were treated with 2μM thapsigargin (Thapsi) for 90min and imaged
using a confocal microscope, except in (A) where cells were imaged without treatment. (A) Co-expression of Golli–YC/STIM1-CT–YN in untreated cells does not result in the formation of EYFP
(n=21 cells). (B) Co-expression of Golli–YC/STIM1-CT–YN results in reconstitution of EYFP ﬂuorescence at the PM when cells were treated with thapsigargin (n=35 cells). (C) Expression
of Golli–YC (n=12 cells) alone, (D) STIM1-CT–YN (n=20 cells) alone, (E) STIM1-CT–YN with YC (n=27 cells) or (F) Golli–YC with YN (n=18 cells) fails to restore EYFP ﬂuorescence in
thapsigargin-treated cells. (G) Similarly, co-expression of the YC and YN proteins gives no EYFP ﬂuorescence following thapsigargin treatment. (H) Treatment of cells with 100μM histamine in
place of thapsigargin also reconstitutes EYFP ﬂuorescence (n=27 cells). EYFP ﬂuorescence from (B) was recorded using the Lambda scan mode. Fluorescence intensity, after 453nm excitation,
was recorded in 5 nm intervals from 510nm to 590nm; the emission spectrum was similar to that of EYFP (I). Scale bars=10μm; a. u., arbituary units.
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Figure 3 For legend, see next page
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placing the protein in a position to regulate the activity of these
proteins. Golli overexpression has been shown to decrease SOCE
following store depletion in Jurkat T cells [24]. If this occurred
throughaninteractionwithSTIM1,theGolliproteinwouldeither
co-localizewithSTIM1inpunctaorwouldpreventSTIM1puncta
formation. To test this, full-length STIM1–EYFP and a Golli-
BG21–mCherry fusion protein were expressed in HeLa cells.
No co-localization between STIM1–EYFP and Golli-BG21–
mCherry was observed in untreated HeLa cells, where STIM1–
EYFP expression was reticular and Golli-BG21–mCherry was
distributed throughout the PM as observed previously [24]
(Figure 3C). However, when cells were treated with thapsigargin
for 10 min before imaging to induce STIM1 puncta formation,
Golli–mCherryexpressionwasobservedpredominantlyatthePM
whereSTIM1–EYFPpunctaaccumulated,butwasalsoseentoco-
localize with STIM1–EYFP in a subset of puncta (Figure 3D and
insert). We also examined whether Golli–GFP co-localized with
punctate STIM1–EYFP and mCherry–Orai1 complexes in HeLa
cells after thapsigargin treatment. Indeed it appeared that all three
proteins co-localized to the same punctate structures (Figure 3E
and insert). We did not see any change in the number of STIM1–
EYFP puncta formed in thapsigargin-treated cells overexpressing
Golli–mCherry compared with control cells expressing STIM1–
EYFP alone (Figure 3F) suggesting that Golli does not affect the
formation of STIM1 puncta itself. The targeting of both proteins
to the same punctate structures suggests that Golli and full-length
STIM1interactandthatGollimayregulateSOCEthroughadirect
interaction with STIM1 in puncta.
To determine whether Golli affects SOCE in HeLa cells, we
transfected cells with Golli–mCherry or STIM1–EYFP alone or
in combination and loaded cells with the cytosolic Ca
2+ indicator,
Fluo 4 AM. Stores were depleted with thapsigargin in Ca
2+-free
medium for approx. 10 min and Ca
2+ inﬂux was measured upon
re-addition of Ca
2+ to the external solution. Untransfected cells in
the same ﬁeld of view as transfected cells were used as internal
controls.Golli-expressingcellsexhibitedareducedrateandextent
of Ca
2+ inﬂux compared with inﬂux in untransfected control cells
(Figure 4A), which was statistically signiﬁcant (P<0.0001) at
the 750 s time point. This is consistent with previous ﬁndings
that Golli-deﬁcient T-cells show enhanced SOCE and that
overexpression of Golli-BG21 inhibits SOCE [24], and suggests
that Golli negatively regulates SOCE. In STIM1-overexpressing
cells there was an increase in the initial rate of SOCE when
compared with untransfected cells (Figure 4A), which we have
observed previously [30]. Interestingly, overexpression of STIM1
abolished the inhibitory effect of Golli-BG21 when compared
with STIM1-overexpressing cells (Figure 4A). This was not due
to differences in the expression of Golli as the level of Golli-
BG21–mCherry ﬂuorescence was similar in cells expressing
Golli-BG21–mCherry alone or in combination with STIM1–
EYFP (Figure 4B). It is therefore possible that high levels of
STIM1 protein expression can directly overcome the inhibition of
SOCE by Golli-BG21.
DISCUSSION
Previous studies identiﬁed Golli-BG21 as a regulator of SOCE.
This has been particularly well established for T-cells where
knockout of Golli increased SOCE and overexpression of Golli-
BG21 decreased SOCE [24]. It was not clear, however, from
these studies whether Golli has a direct effect on the SOCC
itself or another protein or pathway involved in the activation
of SOCE. In the present study, we suggest that Golli directly
interactswiththemasterSOCEregulatorSTIM1toreduceSOCE.
The C-terminal domain of STIM1 successfully bound to Golli
in GST-binding assays and BiFC assays. We have not mapped
the STIM1-interacting domain within Golli, but it is possible
that this is an epitope that is shared with the classical MBP
proteingiventheC-terminusofSTIM1bindstoMBPfrombovine
brain extract in pull-down assays. We have shown in the present
study, using a BiFC assay, that the interaction between Golli-
BG21 and the C-terminus of STIM1 can be detected in cells
after stimulation by both thapsigargin and histamine treatment.
Both of these compounds should produce changes in cyto-
solic Ca
2+ levels but, unlike thapsigargin, histamine elicits
transientCa
2+ oscillationsinHeLacells[36,37].Astheformation
ofSTIM1–EYFPpunctawasnotobservedunderconditionswhere
histamine stimulated BiFC ﬂuorescence between STIM1–YN
and Golli–YC, it is possible that it is the modulation of the
cytosolic Ca
2+ concentration by both thapsigargin and histamine
rather than sustained translocation of endogenous STIM1 that
induces an interaction between the C-terminus of STIM1 and
Golli-BG21. The BiFC assay was used in the present study since
it is a more robust method for investigating protein interactions
in live cells than other techniques such as FRET (ﬂuorescence
resonance energy transfer). It is important to note, however, that
the BiFC assay is not reﬂective of the kinetics of the interaction,
since binding between the YC and YN fragments of EYFP is
essentially irreversible and refolding of the full EYFP protein
and the reconstitution of ﬂuorescence requires some time [33],
in this case, up to 90 min. Irrespective of the lack of information
fromtheseexperimentsonthekineticsoftheSTIM1–Golli-BG21
interaction, this assay provides the most convincing evidence of
a direct protein–protein interaction in living cells.
No ﬂuorescence complementation was observed in cells
expressingGolli–YCandOrai1–YN,orGolli–YCandfull-length
STIM1–YN (results not shown). EYFP ﬂuorescence was also
absent in cells expressing Orai1–YC and STIM1-CT–YN (results
not shown), even though the STIM1 and Orai1 proteins are
known to interact [16,34,38]. There are several reasons why
this may have occurred. First, fusion of an EYFP fragment
to a protein may alter the structure of the protein, thereby
abolishing an interaction domain within the protein of interest
[39].Secondly,thearrangementoftheBiFCfusionproteinswithin
a protein complex may sterically hinder an interaction between
the complementary EYFP fragments and prevent the formation of
functional EYFP [39]. The lack of EYFP ﬂuorescence between
Figure 3 STIM1, Orai1 and Golli co-localize in HeLa cells
(A) HeLa cells were co-transfected with STIM1-CT–YN/Golli-YC and mCherry–Orai1. At 24h post-transfection, cells were treated with 2μM thapsigargin for 90min and imaged using a confocal
microscope. Reconstituted EYFP ﬂuorescence from STIM1-CT–YN/Golli–YC co-localizes with mCherry–Orai1. (B) STIM1-CT–EYFP, mCherry–Orai1 and Golli-BG21–GFP show co-localization in
HeLa cells (the enlarged insert is taken from the top left of the cell). (C) Full-length STIM1–EYFP does not co-localize with Golli-BG21–mCherry in untreated cells. (D) STIM1–EYFP puncta show
co-localization with Golli-BG21–mCherry in thapsigargin-treated HeLa cells (the enlarged insert is taken from the top of the cell). (E) Full-length STIM1–EYFP, mCherry–Orai1 and Golli-BG21–GFP
show co-localization in puncta following thapsigargin treatment in HeLa cells (the enlarged insert is taken from the middle left side of cell). (F) Cells expressing STIM1–EYFP alone (n=43) or in
combination with Golli-BG21–mCherry (n=19) were analysed and the number of puncta formed following thapsigargin treatment counted and expressed as the mean number per cell (+ −S.E.M.).
There was no signiﬁcant difference in the number of STIM1 puncta formed in the presence or absence of Golli-BG21–mCherry. Scale bars=10μm.
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Figure 4 Overexpression of Golli reduces store-operated Ca2+ inﬂux, but
this is reversed by overexpression of STIM1
(A) HeLa cells were transfected with Golli-BG21–mCherry and/or STIM1–EYFP. At 24h
post-transfection, cells were loaded with 5 μM Fluo 4 at room temperature for 30min.
Cells were treated with 2 μM thapsigargin to deplete the stores, followed by the readdition
of 2mM Ca2+ to the external solution. Changes in [Ca2+]i were measured and compared
in transfected and untransfected cells. The results are means+ −S.E.M. For untransfected
cells, n=154 cells; for Golli-BG21–mCherry-transfected cells, n=63 cells; for STIM1–EYFP
transfected cells, n=36 cells; for Golli-BG21–mCherry- and STIM1–EYFP-transfected cells,
n=55 cells. (B) Golli-BG21–mCherry ﬂuorescence was quantiﬁed in cells expressing
Golli-BG21–mCherry alone (n=175) or together with STIM1–EYFP (n=128). Expression
levels of Golli-BG21–mCherry were similar in both conditions.
Golli–YC and Orai1–YN, and Golli–YC and full-length STIM1-
YN proteins is therefore not conclusive evidence for the absence
of an interaction between these protein pairs. We also could not
conﬁrm the potential interaction of Orai-NT to GST–Golli-BG21,
seen in the initial GST pull-down from brain extract, in a direct
binding assay with recombinant proteins.
Despite the large amount of recent research into the activation
of SOCCs, very few interacting partners have been found for
STIM1 and Orai1. One recent study has identiﬁed a novel EF-
hand-containingproteinCRACR2A(CRACregulator2A),which
binds to both STIM1 and Orai1 to stabilize their interaction,
thereby enhancing SOCE in T-cells [40]. Additionally, little is
known about the Ca
2+-dependent inactivation of these channels.
One recent study reported that both calmodulin and a short
negatively charged region within the STIM1 C-terminus can bind
to Orai1 to inactivate SOCE [41]. Interestingly, in the present
study,Golli-BG21co-localizedwithSTIM1andOrai1complexes
after store depletion. The ability of Golli-BG21 to bind STIM1
puncta in a Ca
2+-dependent manner may be key to its regulation
of SOCE. It is possible that Golli-BG21 binds to STIM1–Orai1
complexes when Ca
2+ levels are already high to reduce the inﬂux
of Ca
2+ into the cell and perhaps may be a further contributor
to the Ca
2+-dependent inactivation of SOCCs. When STIM1 was
overexpressed with Golli-BG21, the inhibitory effect of Golli-
BG21 on SOCE was abolished. This was not due to variation in
the expression levels of Golli-BG21 achieved in the presence and
absenceofSTIM1,suggestingthataninteractionbetweenSTIM1
and Golli-BG21 overcomes the ability of Golli to reduce SOCE.
To date, studies on MBP and Golli, and their regulation of
Ca
2+ channels, have focussed exclusively on oligodendrocyte
precursor cells and T-cells. Of the three Golli isoforms cloned,
the BG21 isoform of Golli is the most widely expressed in many
different tissues, other than nervous tissues, including the heart,
kidney, spleen and lung [23], although its function in these tissues
has not been elucidated. The widespread distribution of Golli-
BG21 suggests that it could be part of a general mechanism
for the regulation of SOCE across many tissue types. Hence,
we propose that Golli-BG21 functions to regulate SOCE via a
directinteractionwithSTIM1,buttheexactmolecularmechanism
underlying this interaction has yet to be deﬁned.
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